cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
Topic: Drug Resistance and New Therapies in Colorectal Cancer

A special issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 30 Jun 2021

Guest Editor(s)

  • Prof. Ugo Testa
    Department of Haematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.

    Website | E-mail

  • Prof. Raffaele Capasso
    Department of Pharmacy, University of Naples Federico II, Naples, Italy.

    Website | E-mail

Special Issue Introduction

Colorectal cancer is the most common gastrointestinal malignancy worldwide. Despite clear medical advances in colon cancer treatment, current therapeutic interventions may fail to prevent disease progression to metastatic dissemination. Therefore, it is crucial to identify the different molecular actors that play key roles in the oncogenesis of colorectal cancer. What can molecules be? Synthetic molecules as well as medicinal plants and their metabolites can play a fundamental role in colorectal cancer.

Submission Deadline

30 Jun 2021

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://cdrjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=611
Submission Deadline: 30 Jun 2021
Contacts: Bella Zhao, Assistant Editor, bella@cdrjournal.com

Published Articles

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties